UNIVERSITY OF COLORADO CANCER CENTER RESEARCHERS WIN $599,999 KOMEN GRANT TO STUDY DIABETES DRUG IN BREAST CANCER
September 30, 2008
September 30, 2008
AURORA, Colo., Sept. 30 -- The University of Colorado at Denver and Health Sciences Center issued the following news release:
Researchers from the University of Colorado Cancer Center (UCCC) have been awarded a $599,999 grant from the Susan G. Komen Foundation for the Cure to investigate whether using a common diabetes drug can stop tumor growth in breast cancer.
"We're beginning to explore the relationship between pre-diabetes syndrome or type II diabetes . . .
Researchers from the University of Colorado Cancer Center (UCCC) have been awarded a $599,999 grant from the Susan G. Komen Foundation for the Cure to investigate whether using a common diabetes drug can stop tumor growth in breast cancer.
"We're beginning to explore the relationship between pre-diabetes syndrome or type II diabetes . . .